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Increased serum levels and epithelial expression of macrophage migration inhibitory
factor in gastric cancer
Harry H-X Xia, Xing Xiang He, Shiu Kum Lam, Yi Yang, Marie C-M Lin, Wai Man Wong, Hsiang Fu Kung, Suet Yi Leung,
Siu Tsan Yuen, Benjamin C-Y Wong. Department of Medicine, Institute of Molecular Biology and Department of Pathology,
The University of Hong Kong, Hong Kong
Introduction: Macrophage migration inhibitory factor (MIF) plays a pivotal role in inflammatory and immune
diseases, and is also implicated in carcinogenesis. This study aimed to determine if serum levels and gastric
epithelial MIF expression are associated with gastric precancerous lesions and cancer.
Method: Ninety patients (M/F, 54/36, age, 56±16 years), 15 with normal gastric mucosa, 15 with H. pylori-associated
chronic antral gastritis, 20 with intestinal metaplasia in the antrum, and 40 with antral adenocarcinoma, were
included in this study. Immunohistochemistry was used to determine MIF expression in gastric epithelial cells, and
enzyme-linked immunosorbent assay (ELISA) was used to measure serum MIF. Five gastric cancer cell lines
(AGS, MKN-45, MKN-28, MGC-803 and SGC-7901) and one non-malignant gastric cell line (GES-1) were
cultured for 24 hours. MIF protein in the supernatant was measured by ELISA, and MIF mRNA in cultured cells
was determined by reverse transcription-polymerase chain reaction.
Results: MIF expression in epithelial cells was weak in normal mucosa (12%), but increased in gastritis (52%),
intestinal metaplasia (66%) and gastric cancer (96%) (P<0.001, ANOVA). Serum MIF level was also increased
with the pathological changes (576±82 pg/ml in normal mucosa, 2100±349 pg/ml in gastritis, 4498±253 pg/ml in
intestinal metaplasia and 9737±1249 pg/ml in gastric cancer, P<0.001, ANOVA). There was a significant
correlation between epithelial MIF expression and serum MIF level (R=0.776, P<0.001). Expression of MIF
protein and mRNA was increased in all cancer cell lines, compared to the non-malignant cell line.
Conclusions: Advanced gastric pathology is associated with a higher MIF expression in epithelial cells. The
epithelial MIF expression directly correlated with serum MIF concentrations. Hence MIF plays a role in gastric
carcinogenesis and serum MIF levels may be an important biomarker for diagnosis and prognosis.
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Restoration of XAF1 expression inhibits gastric and colonic tumorigenesis in vivo
Shui Ping Tu*, Jiantao Cui*, Marie C.M. Lin**, Xiao Hua Jiang*, Yi Yang*, Ching Tung Lum**, ST Yuen^, SY Leung^,
Shiu Kum Lam*, Hsiang Fu Kung**, Benjamin Chun Yu Wong*. Department of Medicine*, Pathology^, and
**Institute of Molecular Biology, University of Hong Kong, Hong Kong.
Introduction: XAF1 ( XIAP-Associated Factor 1 ) is identified as a novel XIAP (X-linked inhibitor of apoptosis )
binding partner. XAF1 antagonizes the anti-caspase activity of recombinant XIAP and reverses the protective effect
of XIAP overexpression in cell lines. In this present study, we investigated the role of XAF1 as a tumour suppressor.
Method: pcDAN3-XAF1 and Adeno-XAF1 plasmids were constructed. Adeno-XAF1 virus was generated. Stable
transfectants were established and characterized. Tumourigenesis was evaluated by the formation of solid tumours
in athymic nude mice xenograft.
Results: Expression of XAF1 was detected only in 50% gastric and colon cancer cell lines, and 54% human colon
cancer tissues expressed low level of XAF1 mRNA compared with adjacent normal colon tissues. Restoration of
XAF1 expression induced apoptosis in gastric and colon cancer cells. Overexpression of XAF1 suppressed
anchorage-dependent and -independent growth, induced cell cycle arrest, and increased the sensitivity to
chemotherapeutic drugs. Furthermore, infection of adeno-XAF1 induced apoptosis in gastric and colon cancer
cells. In nude mice, overexpression of XAF1 suppressed tumorigenesis in stable gastric and colon cancer transfectants
expressing XAF1. Gastric and colon cancer cells infected with adeno-XAF1 either lost their tumourigenic potential
or formed tumours of smaller size and markly delayed onset when compared with those infected with adeno-LacZ
and uninfected cells.
Conclusion:These results demonstrated that XAF1 is a tumour suppressor and has strong proapoptotic activity in
gastric and colon cancer. XAF1 may be an ideal candidate for cancer therapy.
